» Articles » PMID: 34113919

Pregnancy-induced Increased Heart Rate is Independent of Thyroid Hormones

Overview
Journal Heart Rhythm O2
Date 2021 Jun 11
PMID 34113919
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The heart rate increases by 10-20 beats per minute (bpm) throughout pregnancy in women, reaching maximum heart rate in the third trimester. During pregnancy, important changes in thyroid hormones also occur, with increases of up to 50% in the levels of triiodothyronine (T), the biological active thyroid hormone. In addition, T has been shown to regulate cardiac electrophysiology.

Objective: Thus, in the present study the potential contribution of T in pregnancy-induced increased heart rate was explored.

Methods: We compared the heart rate between nonpregnant and pregnant mice under control conditions and after altering thyroid hormone levels with T and propylthiouracil (PTU, an antithyroid drug) treatments.

Results: Consistent with the clinical data, we found a 58% rise in T levels during pregnancy in mice. Although pregnant mice had a higher baseline heart rate (607 ± 8 bpm, = .004) and higher T levels (1.9 ± 0.4 nM, = .0005) than nonpregnant mice (heart rate: 546 ± 16 bpm; T levels: 1.2 ± 0.1 nM), their heart rate responded similarly to T treatment as nonpregnant mice (nonpregnant: Δ130 ± 22 bpm; pregnant: Δ126 ± 17 bpm, = .858). Additionally, the heart rate remained significantly elevated (607 ± 11 bpm, = .038) and comparable to untreated pregnant mice, after the use of the antithyroid drug PTU, although T levels (1.3 ± 0.2 nM, = .559) returned to nonpregnant values.

Conclusion: Based on these results, it is unlikely that T contributes significantly to the pregnancy-induced increased heart rate.

Citing Articles

Cardiac automaticity is modulated by IKACh in sinoatrial node during pregnancy.

Long V, El Gebeily G, Leblanc E, Senhadji M, Fiset C Cardiovasc Res. 2024; 120(17):2208-2219.

PMID: 39259837 PMC: 11687396. DOI: 10.1093/cvr/cvae200.


Maternal Exercise Before and During Pregnancy Facilitates Embryonic Myogenesis by Enhancing Thyroid Hormone Signaling.

Gao Y, Zhao L, Son J, Liu X, Chen Y, Deavila J Thyroid. 2022; 32(5):581-593.

PMID: 35286177 PMC: 9145266. DOI: 10.1089/thy.2021.0639.

References
1.
Gowda R, Khan I, Mehta N, Vasavada B, Sacchi T . Cardiac arrhythmias in pregnancy: clinical and therapeutic considerations. Int J Cardiol. 2003; 88(2-3):129-33. DOI: 10.1016/s0167-5273(02)00601-0. View

2.
Shugg T, Egly C, Stamatkin C, Patil A, Tisdale J, Overholser B . Progesterone Metabolites Inhibit the Human Ether-a-go-go-Related Gene and Predict QT Interval Length. J Clin Pharmacol. 2019; 60(5):648-659. PMC: 10170396. DOI: 10.1002/jcph.1563. View

3.
Shimoni Y, Severson D . Thyroid status and potassium currents in rat ventricular myocytes. Am J Physiol. 1995; 268(2 Pt 2):H576-83. DOI: 10.1152/ajpheart.1995.268.2.H576. View

4.
Ojamaa K, Kenessey A, Klein I . Thyroid hormone regulation of phospholamban phosphorylation in the rat heart. Endocrinology. 2000; 141(6):2139-44. DOI: 10.1210/endo.141.6.7514. View

5.
Valcavi R, Menozzi C, Roti E, Zini M, LOLLI G, Roti S . Sinus node function in hyperthyroid patients. J Clin Endocrinol Metab. 1992; 75(1):239-42. DOI: 10.1210/jcem.75.1.1619016. View